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Abstract
Background: Intestinal microbiota play an important role in maintaining the homeostasis of the host immune
system. To analyze the alteration of the intestinal microbial community structure in Korean Crohn’s disease (CD)
patients, we performed a comparative metagenomic analysis between healthy people and CD patients using fecal
samples and mucosal tissues of ileocecal valve.
Methods: 16S rRNA genes from fecal samples or mucosal tissues of 35 CD patients and 15 healthy controls (HC)
were amplified using a universal primer set and sequenced with GS FLX Titanium. The microbial composition and
diversity of each sample were analyzed with the mothur pipeline, and the association between microbial
community and clinical characteristics of the patients were investigated.
Results: The contribution of bacterial groups to the intestinal microbial composition differed between CD and HC,
especially in fecal samples. Global structure and individual bacterial abundance of intestinal microbial community
were different between feces and ileocecal tissues in HC. In CD patients with active stage, relative abundances of
Gammaproteobacteria and Fusobacteria were higher in both fecal and mucosal tissue samples. Moreover, the
intestinal microbial community structure was altered by anti-tumor necrosis factor (anti-TNF) treatment.
Conclusions: Our 16S rRNA sequence data demonstrate intestinal dysbiosis at the community level in Korean CD
patients, which is similar to alterations of the intestinal microbial community seen in the western counterparts.
Clinical disease activity and anti-TNF treatment might affect the intestinal microbial community structure in CD
patients.
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Background
Microbes in the body are tenfold more than the number
of human cells, and encode 100 times more unique
genes than human genomes. Intestinal microbiota are in
close contact with mucosal immune system, affecting
host physiology and maintaining homeostasis [1–3]. The
incidence of Crohn’s disease (CD) has been reported to
be increasing around the world, and while it is respon-
sible for inducing chronic intestinal inflammation in a
genetically susceptible host, the underlying mechanism
is thought to result from an inappropriate and ongoing
activation of the mucosal immune system driven by
several stimuli such as intestinal microbiota and various
environmental factors [4].
CD is relatively more prevalent in western popula-
tion, and numerous genetic susceptibility loci have
been identified [5–7]. However, well-known CD sus-
ceptible genes such as NOD2 and ATG16L1 did not
show replication results in Asian population, suggest-
ing a different genetic background [8, 9]. Although the
genetic susceptibility loci differ between Asian and
western population, the incidence of CD in Asian
population is increasing with similar immunologic
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phenomena [10]. Therefore, it can be presumed that
environmental factors, especially intestinal commensal
bacteria, besides genetic factors, play a fundamental
role in the development of CD. In fact, it is well known
that the intestinal microbial community of western CD
patients demonstrates dysbiosis different from healthy
population [11, 12]. However, there is no published
study demonstrating intestinal microbial profiles of
Korean CD patients using high throughput sequencing
methods.
In the present study, we examined and compared the
fecal and mucosal microbial community of Korean CD
patients and healthy controls (HC) by applying a next-




We collected stool or mucosal tissue specimens from
CD patients who underwent colonoscopic examination
and from similar age group of HC who also underwent
colonoscopic examination for screening in Hanyang
University Guri Hospital. Controls consisted of healthy
subjects aged 18 years and older. HC had no evidence of
active inflammatory conditions of the gastrointestinal
tract. Patients with a history of inflammatory bowel dis-
ease, colon cancer, colonic resection, or hospital admis-
sion in the previous 3 months, or presence of chronic
illness (such as renal failure, diabetes, or cardiopulmo-
nary diseases), were excluded from HC. All of the en-
rolled CD patients and HC had not taken antibiotics in
the previous 3 months. The study was approved by the
institutional review board of Hanyang University Guri
Hospital (GURI 2012-05-022). Written informed consent
for participation and publication was obtained from all
participants prior to the enrollment of this study.
Sample collection and sequencing
Stool samples were collected in sterile containers at
home before the start of bowel preparation and stored at
4 °C. Upon arrival at the hospital, the stool samples were
frozen at −80 °C. Mucosal tissue samples were taken
from the ileoceal valve area using sterile endoscopic bi-
opsy forceps during colonoscopic examination and im-
mediately stored at −80 °C. After homogenization, DNA
was extracted using a phenol/chloroform extraction
method combined with physical disruption of bacterial
cells and the UltraClean microbial DNA Isolation kit (Mo
Bio Laboratories, Carlsbad, CA, USA). The DNA concen-
tration and quality were determined by agarose gel elec-
trophoresis (1 % wt/vol agarose in Tris-acetate-EDTA
buffer) and with a NanoDrop ND-1000 spectrophotom-
eter (NanoDrop Technologies, Wilmington, DE, USA).
DNA spanning the V1-V3 region of bacterial 16S rDNA
was amplified using a barcoded universal primer (8F 5′-
barcode sequence-linker sequence (AC)-GAGTTTGA
TCMTGGCTCAG-3′ or GGGTTCGATTCTGGCTCAG
for Bifidobacterium) and 518R 5′-barcode sequence-linker
(AC)- WTTACCGCGGCTGT GG-3′). Sequencing was
conducted with Roche GS FLX Titanium platform accord-




The sequences were basically analyzed using the
MOTHUR pipeline [13]. Sequence trimming was con-
ducted in sixth steps. In the first step, the sequence trim-
ming was conducted at the flowgram level with
recommended values for Titanium data that were mini-
mum flow value of 360 and maximum flow value of 720.
In the second step, PyroNoise that removes homopolymer
length error from 454 pyrosequencing was used for
removal of base-call errors. In the third step, the primer
and barcode sequences were removed and reverse-
complement of some sequences was conducted. In the
fourth step, human sequences were removed with BMTag-
ger. In the fifth step, the chimera sequences were removed
with UCHIME after Nearest Alignment Space Termin-
ation (NAST) alignment against the SILVA database. In
the final trimming step, sequences less than 250 bases
were removed. After completion of trimming, high-quality
sequences were used for the bacterial community analysis.
Taxonomic assignment and taxonomic comparison
Taxonomic assignment of the high-quality reads was
conducted using RDP classifier [14] which is a naïve
Bayesian classifier and uses the RDP database. Among
the taxonomically assigned reads, the reads with a confi-
dence estimate of more than 0.8 were used for the taxo-
nomic comparison. After taxonomic assignment of each
read, the proportions of each bacterial group were calcu-
lated in each sample. The taxonomic comparisons be-
tween groups were conducted with the average relative
abundance of each bacterial group in each sample group
and standard error (SE) of the average relative abun-
dance was calculated. For the clustering analysis, a heat-
map was constructed with R script using the relative
abundances of each bacterial class in the tissue samples
of the patients and calculation of Euclidean distance and
complete-linkage clustering was conducted. Wilcoxon
signed-rank test in SPSS program (version 21, Inc.,
Chicago, IL) was used for the calculation of significant
probability (p-value).
Diversity indices
Rarefaction, coverage, the total number of species ob-
served in a sample (sobs), richness diversity indices
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such as abundance-based coverage estimators (ACE)
and Chao estimator and even diversity indices such as
Jackknife estimator, Shannon index, Inverse Simpson
index were calculated with the unique sequences of
each sample. For the calculation of diversity indices,
unique sequences were selected by the mothur com-
mand ‘unique.seqs’ and distance matrix was generated
with the mothur command ‘dist.seqs’ and clustered
using phylip. Rarefaction was calculated with the
mothur command ‘rarefaction.single’ and rarefaction
curves were generated in Excel program. The coverage,
sobs, and diversity indices were calculated with the
mothur command ‘summary.single’. Wilcoxon signed-
rank test was used for the calculation of p-value.
Principal coordinate analysis and UniFrac distance
For the principal coordinate analysis (PCoA), and calcu-
lation of UniFrac distance, representative sequences at
the 3 % dissimilarity level were extracted from each sam-
ples and an environment file, which is containing the
read information including the number of reads assigned
to each representative sequences was generated. Dis-
tance matrix was constructed after NAST alignment
against the SILVA database. The distance file was used
for the tree generation using neighbor program [15] and
the final PCoA results were generated with UniFrac.
Program [16]. UniFrac distances were calculated with
mothur command ‘unifrac unweighted’.
Nucleotide sequence accession number
The DNA sequences from this metagenomic project
have been deposited in the NCBI Short Read Archive
under the bio-project number PRJNA240658.
Results
Patient characteristics and sequencing data
For the analysis of the intestinal microbial community, we
collected 45 samples (10 feces and 35 mucosal tissues)
from 35 CD patients and 30 samples (15 feces and 15
mucosal tissues) from 15 HC. Similar to the characteristics
of CD patients reported in Korea, the CD group in the
present study was male dominant with a mean age of
28.1 years. The mean period of disease duration was
54.9 months. Twenty-six patients had L3 lesions as de-
fined by the Montreal classification [17] and 31.4 % of pa-
tients had peri-anal lesions. Fifteen patients were in active
state, while 20 patients were in clinical and endoscopic re-
mission state (Table 1).
After read trimming, average 6341 and 6312 high
quality reads were obtained from the fecal and mucosal
tissue samples of HC, respectively (see Additional file 1:
Table S1). From the CD patients, average 6698 and
11,363 high quality reads were obtained from the fecal
and mucosal tissue samples, respectively.
Global bacterial structure differed between feces and
mucosal tissues in HC
We have compared the intestinal microbial community
between fecal samples and mucosal tissue samples in
HC. Bacteroidetes and Firmicutes were the major domin-
ant bacterial phyla in the fecal samples of HC. On the
contrary, the microbial community of the mucosal tissue
samples of HC was mainly dominated with Bacteroi-
detes, Firmicutes, and Proteobacteria (Fig. 1a). Moreover,
PCoA also showed the certain clustering pattern be-
tween the fecal and mucosal tissue samples in HC
(Fig. 1b). The rarefaction curves and the values of the di-
versity indices between the fecal samples and tissue sam-
ples of HC indicated that the fecal microbiota have more
richness values than the mucosal microbiota (Fig. 1c, d).
However, there was no significant difference in the even-
ness diversity indices except for the Jackknife estimator.
The intestinal microbial composition differed between CD
and HC
At the phylum level, the relative abundance of Proteo-
bacteria was increased in both fecal and mucosal tissues
of CD patients compared to HC. Interestingly, the
Table 1 Clinical characteristics of enrolled subjects
HC CD
Number of subjects 15 35
Number of samples 30 45
Male:Female 14:1 26:9
Mean age (year) 35.0 28.1
BMI (kg/m2) 23.9 21.2
Mean disease duration (month) – 54.9
Montreal classificationa (No. of patients) – L1B1 (2), L1B2 (2), L2B1 (4), L2B2 (1), L3B1 (17), L3B2 (5), L3B3 (4)
Perianal involvement (No. of patients) – 11 (31.4 %)
Medication (No. of patients) – Prednisolone (5), 5-ASA (30), Azathioprine (22), Infliximab (9)
HC healthy control, CD Crohn’s disease, BMI body mass index, 5-ASA 5-aminosalicylic acid. a Disease location and behavior are classified as L1-3 and B1-3, respectively;
L1, ileal location; L2, colonic location; L3, ileocolonic location; B1, inflammatory behavior; B2, structuring behavior; B3, penetrating behavior
Eun et al. BMC Gastroenterology  (2016) 16:28 Page 3 of 11
relative abundance of Fusobacteria was increased in the
mucosal tissue samples of CD patients compared to HC,
while the relative abundance of Actinobacteria was in-
creased in the fecal samples of CD patients, although
these differences were not statistically significant (Fig. 2a).
At the class and family level, the relative abundances
of Enterobacteriaceae of Gammaproteobacteria and
Fusobacteriaceae of Fusobacteria were increased in mu-
cosal tissue samples of CD patients compared to HC.
Meawhile, in the fecal samples of CD patients, the relative
abundances of Enterobacteriaceae and Pseudomonadaceae
(p = 0.043) of Gammaproteobacteria, Streptococcaceae of
Bacilli, and Erysipelotrichaceae of Erysipelotrichia were
increased. These increase of relative abundances of
Gammaproteobacteria and Bacilli in the fecal and
mucosal tissues lead to concomitant decrease in the
relative abundances of other classes and families
such as Bacteroidaceae and Prevotellaceae (p = 0.028)
of Bacteroidia, Lachnospiraceae (p = 0.028) and
Ruminococcaceae (p = 0.028) of Clostridia, and Veil-
lonellaceae (p = 0.017) of Negativicutes (Fig. 3, see
Additional file 1: Table S2).
Fig. 1 Intestinal microbial community structure in fecal and mucosal tissue samples of healthy control. a Taxonomic comparison at the phylum
level. The numbers in parenthesis indicate the standard errors; b PCoA plot; c rarefaction curves; d diversity indices at the 3 % dissimilarity level.
Chao and ACE indicate the richness diversity index. Jackknife, Shannon and Inverse Simpson indexes indicate the eveness diviersity index
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The diversity indices of fecal samples of CD patients
were significantly decreased compared to those of HC,
but there was no significant dfference of the diversity in-
dices of the mucosal tissue samples between CD patients
and HC (Figs. 1d and 2d). The taxonomic comparison
also showed more significant differences of the fecal
samples between CD and HC compared to mucosal tis-
sue samples (Fig. 3, see Additional file 1: Table S2).
Moreover, PCoA and UniFrac distance showed that
similarity of the mucosal bacterial community between
CD and HC was high, while similarity of the fecal
bacterial community between two groups was very low
(Fig. 4).
Certain microbial population was related to clinical
disease activity in CD patients
The relative abundances of Gammaproteobacteria and
Fusobacteria were higher in both fecal and mucosal tis-
sues of active-stage CD patients than CD patients with-
out any active ulcer, although there was no significant
difference (Fig. 5). At the genus level, the relative abun-
dances of Escherichia/Shigella and Pseudomonas of
Fig. 2 Intestinal microbial community structure in fecal and mucosal tissue samples of Crohn’s disease patients. a Taxonomic comparison at the
phylum level. The numbers in parenthesis indicate the standard errors; b PCoA plot; c rarefaction curves; d diversity indices at the 3 %
dissimilarity level. Chao and ACE indicate the richness diversity index. Jackknife, Shannon and Inverse Simpson indexes indicate the eveness
diviersity index
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Gammaproteobacteria and Fusobacterium of Fusobac-
teria were increased in both fecal and mucosal tissues of
active CD patients. Interestingly, Pseudomonas was
nearly absent in the fecal samples of HC, but its abun-
dance was markedly increased in the fecal samples of ac-
tive CD patients. On the other hand, the relative
abundance of Morganella, which was only detected in the
mucosal tissue samples, was increased in the active CD
patients compared to CD patients with inactive stage. In
the stool samples, the relative abundances of Prevotella,
Lachnospiraceae, Faecalibacterium, and Clostridium
XIVa were decreased in the active CD patients compared
to HC (see Additional file 1: Table S3).
Analysis of the microbial community of CD patients at
the class level according to disease location and behavior
showed that the relative abundance of Gammaproteo-
bacteria was highest in the fecal samples of patients with
Montreal classification L3 and B2 lesions. Fusobacteria
was also predominantly observed in both fecal and mu-
cosal tissue samples of patients with L3 and B2 lesions
(Fig. 6, see Additional file 1: Table S4).
Therapeutic medications can affect the microbial
population in CD patients
Comparison of the difference on microbial community
in CD patients according to the application of thera-
peutic medications revealed that a discrete clustering
trend was seen between infliximab-treated group and
infliximab-untreated group (Fig. 7). In addition, the rela-
tive abundance of Gammaproteobacteria in both fecal
and tissue samples was increased in infliximab-treated
group compared to infliximab-untreated group patients,
while the relative abundance of Fusobacteria in both
fecal and tissue samples was decreased in infliximab-
Fig. 3 Taxonomic comparison of fecal and mucosal tissue samples between healthy control and Crohn’s disease patients at the class and family levels
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treated group, although there was no significant differ-
ence (see Additional file 1: Table S5).
Discussion
Our deep sequencing study showed that the intestinal mi-
crobial community in Korean CD patients differed from
that of HC. The dysbiosis patterns in Korean CD patients,
including decreased microbial diversity, increased relative
abundances of Proteobacteria and Fusobacteria and de-
creased proportions of Firmicutes and Bacteroidetes, were
similar to those of western CD patients. In addition, the
intestinal microbial community structure of mucosal tis-
sues samples differed from that of fecal samples. Finally,
we demonstrated that the intestinal microbial community
in CD patients was affected by clinical disease activity, dis-
ease location and behavior, and therapeutic medication
such as anti-TNF agent.
Intestinal microbiota maintain the homeostasis of our
body by keeping close contact with the host [18]. CD af-
fects intestinal commensals in genetically susceptible
hosts through various environmental factors, and exces-
sive stimuli of the immune system ultimately leads to
full-blown disease [19]. Compared with western popula-
tion, Korean CD patients have distinct epidemiologic char-
acteristics such as male predominance, frequent peri-anal
lesions, and distinctive ileo-colonic manifestations, and the
susceptibility genes commonly seen in western countries
are rarely detected in Korean CD patients [9, 20]. However,
since NOD2 and ATG16L1 mutations, which are closely re-
lated with bacterial handling, are observed in western CD
population [5], and although not the same mutation,
ATG16L2 mutation related with regulation of bacteria-
related signal was observed in Korean CD patients [9], it
can be presumed that intestinal microbiota play an import-
ant role in the development of CD [21].
In the present study, Korean CD patients demonstrated
alterations of intestinal microbial community structure
differed from that of HC. The microbial diversity was de-
creased and the relative proportions of Proteobacteria and
Fusobacteria were increased with concomitant decrease of
Fig. 4 Unweighted UniFrac distance (a) and PCoA plot (b) between healthy control and Crohn’s disease patients
Fig. 5 Taxonomic comparison of fecal and mucosal tissue samples
between healthy control and Crohn’s disease patients at the class
level according to the clinical disease activity
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relative abundances of Firmicutes and Bacteroidetes in CD
patients compared to HC, especially in stool samples.
These results are consistent with those of previous studies
from western population [22, 23], suggesting an essential
role of the intestinal microbial community in the develop-
ment of CD throughout the world.
It has been well known that the relative proportions of
Proteobacteria including adherent invasive E. coli and
other numerous bacteria are increased in the mucosa of
inflammatory bowel diseases (IBD) patients [24, 25]. In
this study, Gammaproteobacteria class accounted for
most of increase in the proportion of Proteobacteria
phylum. And, Escherichia/Shigella genus were predom-
inantly observed in both mucosal tissues and fecal sam-
ples of CD patients compared to HC, agreeing that E.
coli strains play an important role in inducing chronic
inflammation of intestinal tract.
On the other hand, the relative abundance of Clostridia
class of Firmicutes phylum were decreased in both fecal
and mucosal tissue samples of CD patients compared to
HC. Firmicutes has been known to synthesize important
short chain fatty acids, mainly acetate, propionate and bu-
tyrate, via fermentation of ingested dietary fiber within the
intestine, which have profound effects on gut health as an
energy source and inflammatory modulator [26]. Since in-
testinal microorganisms are closely related to food [11], it
is interesting to know that decrease of relative proportion
of Firmicutes was consistently observed in both Korean
and western CD patients, even though the diet pattern of
Korean patients is different from that of western counter-
part. Clostridia class has also been reported to induce
colonic regulatory T cells, which have a central role in the
suppression of intestinal inflammation [27]. In addition, we
showed that the relative proportions of Faecalibacterium
Fig. 6 Taxonomic comparison of (a) mucosal tissues and (b) fecal samples between healthy control and Crohn’s disease patients at the class level
according to the disease location and behavior
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and Lachnospiraceae were decreased in the fecal samples of
CD patients. Faecalibacterium prausnitzii, an important
protective commensal bacteria, has been known to be de-
creased in CD patients [28].
In the present study, we compared the intestinal mi-
crobial community between fecal samples and mucosal
tissue samples in HC. In contrast to predominant pro-
portions of Firmicutes and Bacteroidetes in fecal sam-
ples, the proportion of Proteobacteria was markedly
increased in mucosal tissue samples with concomitant
decrease of Firmicutes and Bacteroidetes. In addition,
PCoA showed certain clustering pattern between fecal
and mucosal tissue samples. Analysis of the microbial
community between feces and mucosal tissues in CD
patients also showed different bacterial community
structures. These data are in accordance with previous
studies demonstrating a considerable difference in compos-
ition between the mucosal and fecal samples [29, 30]. Con-
sidering mucosal associated bacterial profiles might have
more important role in IBD than luminal bacteria, it is im-
portant to know that fecal microbial analysis does not fully
reflect mucosal bacterial community structure [31].
It is well known that the intestinal microbial commu-
nity of CD patients demonstrates dysbiosis different
from healthy population [11, 12]. However, whether the
changes of intestinal microbial composition in CD are
primary or secondary events has not been determined
yet. Transmission of colitis with fecal transplant from
diseased donor to wildtype recipient, association of dys-
biosis with genetic polymorphisms, and induction of im-
mune mediated colitis through mono-association with
commensal bacteria suggest dysbiosis as a primary cause
of IBD. Meanwhile, similar dysbiotic patterns in nonspe-
cific intestinal inflammation or infection, increased mu-
cosal associated bacteria in patients with infectious
colitis, and reversal of dysbiotic pattern with steroid
treatment in IBD patients suggest secondary events of
dysbiosis [32]. In our study, certain intestinal microbial
population was related to clinical disease activity in CD
patients. The relative abundances of Gammaproteobac-
teria and Fusobacteria were higher in both fecal and
mucosal tissues of active-stage CD patients than
inactive-stage CD patients. These results agree with sev-
eral previous reports demonstrating disparities of intes-
tinal microbial community between active versus
quiescent IBD [33, 34]. We also demonstrated that the
intestinal microbial composition in CD patients was re-
lated to disease location and behavior. Moreover, anti-
TNF (infliximab) treatment affected a change in the in-
testinal microbial community structure in CD patients.
These our results suggest dysbiosis as a secondary
change of intestinal inflammation in CD.
This is the first study showing the unique change of in-
testinal microbiota community after infliximab treatment.
5-aminosalicylic acid (5-ASA), which is used for the treat-
ment of IBD, activates peroxisome proliferator-activated
receptor-r and affects luminal pH and intestinal mucosal
pro-inflammatory cytokines. Although 5-ASA has previ-
ously been shown to alter the mucosal microbiota com-
position [29, 35], these effects of 5-ASA were not seen in
our study because most of the enrolled patients had been
taking 5-ASA. In contrast, a definitive clustering trend of
microbial clades and differences of relative bacterial pro-
portion were observed between infliximab-treated group
and infliximab-untreated group. Interestingly, the relative
abundance of Gammaproteobacteria was increased in
both fecal and mucosal tissue samples of the infliximab-
treated group. However, the differences of relative
Fig. 7 Construction of heatmap plot and clustering of the mucosal
tissue samples of Crohn’s disease patients. The heatmap plot shows the
relative abundance of the major three bacterial class of each patient. The
dots colored by yellow, blue, red, and green indicate treatment of
infliximab, prednisolone, 5-ASA, and azathioprine, respectively
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bacterial abundances between two groups were not signifi-
cantly different. In addition, we did not investigate the se-
quential changes of intestinal microbial composition in
same patients before and after infliximab treatment. Con-
sidering that the proportion of Proteobacteria increases as
the severity of inflammation worsens, it is possible that
the patients in the infliximab-treated group have more se-
vere intestinal inflammation. Further studies are war-
ranted to confirm potential influence of infliximab
treatment on intestinal microbial community in CD
patients.
In this study, the relative abundance of Fusobacterium
genus was increased in both fecal and mucosal tissue
samples of CD patients compared to HC. In addition,
the proportion of Fusobacteria class were higher in CD
patients with Montreal classification L3 lesion, which in-
volves both small and large intestines. Moreover, the
relative proportion of Fusobacteria class was decreased
in the infliximab-treated group. Fusobacteria has re-
cently become the bacterial strain of concern because of
its relationship with IBD and colorectal cancer [36, 37].
Fusobacterium nucleatum is associated with chronic in-
flammation of the oral cavity, and it is commonly cul-
tured from the intestinal mucosa of IBD patients.
Because of its invasiveness, it is closely related with in-
testinal inflammation. Further studies using genetically
susceptible mice monoassociated with Fusobacteria spe-
cies will be needed to confirm whether this bacterial
strain plays an important role in the development of
chronic colitis as a pathobiont.
Our study faces several limitations. First of all, analysis
at the species level could not be performed due to the
technical limitations of metagenomic sequencing, and
the extraordinary cost of whole genome sequencing. Sec-
ondly, most of our sequencing data regarding the differ-
ences of relative abundances of specific bacteria between
groups could not reach statistically significant because of
small sample size and relatively high variability of micro-
bial composition in each group. Further study with a
large population is required to confirm our data regard-
ing such bacterial profiles of feces and mucosal tissues
in Korean CD patients. Thirdly, in the present study, the
effects of age on the intestinal microbial composition
were minimized by enrolling Korean CD patients whose
age was within the limits of CD prevalence and an age-
matched HC group.
Conclusions
Our study provides novel data that Korean CD patients
demonstrate dysbiosis similar to western CD patients,
who have different genetic and epidemiological back-
grounds, implying that the intestinal microbial commu-
nity may play an essential role in the development of
CD. In addition, the intestinal microbial community
structures are affected by clinical disease activity, disease
location and anti-TNF treatment, suggesting dysbiosis as
a secondary phenomenon of intestinal inflammation in
CD. These results might provide a clue in understanding
the pathogenesis of IBD in different genetic and epide-
miologic backgrounds. Further comprehensive investiga-
tions involving the integration of genetic, microbiome,
and immunologic aspects will hold a great promise for
the prospect of personalized medical care in IBD field.
Additional file
Additional file 1: Table S1. Summary of Sequence Data of the Enrolled
Samples. Table S2. Average Relative Abundance of Intestinal Microbiota
at the Class and Family Levels. Table S3. Average Relative Abundance of
Intestinal Microbiota at the Genus Level According to Clinical Disease
Activity. Table S4. Taxonomic Comparison at the Class Level According
to Disease Location and Behavior. Table S5. Taxonomic Comparison at
the Class Level According to Treatment of Anti-TNF Agent. (DOCX 60 kb)
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
CSE and MJK participated in the design of the study; participated in data
acquisition; performed data analysis and interpretation; wrote the
manuscript. DSH conceived the study; participated in the design of the
study; performed critical revision of manuscript for intellectual content;
performed the study supervision. ARL participated in data acquisition. DIP
and SKY participated in data acquisition; participated in data analysis and
interpretation. YSK and JFK participated in data analysis and interpretation.
All authors read and approved the final manuscript.
Acknowledgements
This work was funded by a grant of the Korean Health Technology R&D
Project, Ministry of Health & Welfare, Republic of Korea (A120176) (DSH).
Author details
1Department of Internal Medicine, Hanyang University Guri Hospital, Guri,
Korea. 2Department of Systems Biology and Division of Life Science, Yonsei
University, Seoul, Korea. 3Department of Internal Medicine, Sungkyunkwan
University, Seoul, Korea. 4Department of Internal Medicine, Ulsan University,
Seoul, Korea. 5Department of Biochemistry, Hanyang University, Seoul, Korea.
Received: 21 October 2015 Accepted: 17 February 2016
References
1. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut
microbes associated with obesity. Nature. 2006;444:1022–3.
2. Relman DA. Microbiology: learning about who we are. Nature. 2012;486:
194–5.
3. Human Microbiome Project Consortium. Structure, function and diversity of
the healthy human microbiome. Nature. 2012;486:207–14.
4. Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet. 2012;380:1590–605.
5. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host-
microbe interactions have shaped the genetic architecture of inflammatory
bowel disease. Nature. 2012;491:119–24.
6. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory
bowel disease. Nature. 2011;474:307–17.
7. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, et
al. Genome-wide meta-analysis increases to 71 the number of confirmed
Crohn’s disease susceptibility loci. Nat Genet. 2010;42:1118–25.
8. Thia KT, Loftus Jr EV, Sandborn WJ, Yang SK. An update on the
epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol.
2008;103:3167–82.
Eun et al. BMC Gastroenterology  (2016) 16:28 Page 10 of 11
9. Yang SK, Hong M, Zhao W, Jung Y, Baek J, Tayebi N, et al. Genome-wide
association study of Crohn’s disease in Koreans revealed three new
susceptibility loci and common attributes of genetic susceptibility across
ethnic populations. Gut. 2014;63:80–7.
10. Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ, et al. Incidence and
phenotype of inflammatory bowel disease based on results from the Asia-pacifi
Crohn’s and colitis epidemiology study. Gastroenterology. 2013;145:158–65.
11. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al.
Diversity of the human intestinal microbial flora. Science. 2005;308:1635–8.
12. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human
gut microbial gene catalogue established by metagenomic sequencing.
Nature. 2010;464:59–65.
13. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, et al.
Introducing mothur: open-source, platform-independent, community-
supported software for describing and comparing microbial communities.
Appl Environ Microbiol. 2009;75:7537–41.
14. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid
assignment of rRNA sequences into the new bacterial taxonomy. Appl
Environ Microbiol. 2007;73:5261–7.
15. Ludwig W, Strunk O, Westram R, Richter L, Meier H, Yadhukumar, et al. ARB: a
software environment for sequence data. Nucleic Acids Res. 2004;32:1363–71.
16. Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing
microbial communities. Appl Environ Microbiol. 2005;71:8228–35.
17. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal
classification of inflammatory bowel disease: controversies, consensus, and
implications. Gut. 2006;55:749–53.
18. Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut
microbiota on human health: an integrative view. Cell. 2012;148:1258–70.
19. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in
inflammatory bowel disease. Nature. 2011;474:298–306.
20. Han DS. Current status and prospects of intestinal microbiome studies.
Intest Res. 2014;12:178–83.
21. Lee YK, Mazmanian SK. Has the microbiota played a critical role in the
evolution of the adaptive immune system? Science. 2010;330:1768–73.
22. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, et
al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a
metagenomic approach. Gut. 2006;55:205–11.
23. Mukhopadhya I, Hansen R, El-Omar EM, Hold GL. IBD-what role do
Proteobacteria play? Nat Rev Gastroenterol Hepatol. 2012;9:219–30.
24. Zitomersky NL, Atkinson BJ, Franklin SW, Mitchell PD, Snapper SB, Comstock
LE, et al. Characterization of adherent bacteroidales from intestinal biopsies
of children and young adults with inflammatory bowel disease. PLoS One.
2013;8, e63686.
25. Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H. Spatial
organization and composition of the mucosal flora in patients with
inflammatory bowel disease. J Clin Microbiol. 2005;43:3380–9.
26. Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota
and host metabolism. Nature. 2012;489:242–9.
27. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al.
Induction of colonic regulatory T cells by indigenous Clostridium species.
Science. 2011;331:337–41.
28. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG,
Gratadoux JJ, et al. Faecalibacterium prausnitzii is an anti-inflammatory
commensal bacterium identified by gut microbiota analysis of Crohn
disease patients. Proc Natl Acad Sci U S A. 2008;105:16731–6.
29. Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, et al.
Dysfunction of the intestinal microbiome in inflammatory bowel disease
and treatment. Genome Biol. 2012;13:R79.
30. Lavelle A, Lennon G, O’Sullivan O, Docherty N, Balfe A, Maguire A, et al.
Spatial variation of the colonic microbiota in patients with ulcerative colitis
and control volunteers. Gut. 2015;64:1553–61.
31. Sartor RB. Gut microbiota: optimal sampling of the intestinal microbiota for
research. Nat Rev Gastroenterol Hepatol. 2015;12:253–4.
32. Sartor RB. Key questions to guide a better understanding of host-
commensal microbiota interactions in intestinal inflammation. Mucosal
Immunol. 2011;4:127–32.
33. Walker AW, Sanderson JD, Churcher C, Parkes GC, Hudspith BN, Rayment N,
et al. High-throughput clone library analysis of the mucosa-associated
microbiota reveals dysbiosis and differences between inflamed and non-
inflamed regions of the intestine in inflammatory bowel disease. BMC
Microbiol. 2011;11:7.
34. Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, et al.
Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm
Bowel Dis. 2009;15:1183–9.
35. Benjamin JL, Hedin CR, Koutsoumpas A, Ng SC, McCarthy NE, Prescott NJ, et
al. Smokers with active Crohn’s disease have a clinically relevant dysbiosis of
the gastrointestinal microbiota. Inflamm Bowel Dis. 2012;18:1092–100.
36. Strauss J, Kaplan GG, Beck PL, Rioux K, Panaccione R, Devinney R, et al. Invasive
potential of gut mucosa-derived Fusobacterium nucleatum positively
correlates with IBD status of the host. Inflamm Bowel Dis. 2011;17:1971–8.
37. Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, et al.
Fusobacterium nucleatum potentiates intestinal tumorigenesis and
modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;
14:207–15.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Eun et al. BMC Gastroenterology  (2016) 16:28 Page 11 of 11
